Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Loss and Comprehensive Loss

v3.25.1
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue $ 0 $ 0
Expenses:    
Research and development, related party 0 3,492
Research and development 15,103 33,273
General and administrative 11,154 15,591
Total expenses 26,257 52,356
Other income/ (expense):    
Interest income 357 1,151
Interest expense, related party (207) 0
Change in fair value of warrants 686 0
Foreign exchange loss (9) (2)
Total other income 827 1,149
Net loss (25,430) (51,207)
Other comprehensive loss:    
Unrealized gain on available-for-sale securities 0 2
Total comprehensive loss $ (25,430) $ (51,205)
Basic loss per common share $ (36.38) $ (227.43)
Diluted loss per common share $ (36.38) $ (227.43)
Weighted average number of common shares outstanding used in the calculation of basic loss per share (in shares) 698,980 225,154
Weighted average number of common shares outstanding used in the calculation of diluted loss per share (in shares) 698,980 225,154